Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Viva Biotech sells 24% stake in CRO business Viva Shanghai for $150m Viva Biotech Holdings Group has announced the fundraising of nearly $150 million by transferring about 24% of its… byPallavi MadhirajuJune 18, 2023